Tag Archives: PH

Do it yourself

Water filtration system issues

Leave a comment

By Johnc00l

I am planning to buy a water distillation system for everyday use. I have an idea to make it better but not sure if it is very effective.

Distilled water has 2 major disadvantages.

1 is that it is acidic because it would dissolve CO2 from the air, so it has a PH of 5.

2 is that it stripes its surroundings from minerals (as if it is starving for minerals). It is non-ionized so it would strip minerals from the pipes it its running through or the human body which causes mineral deficiencies.

My idea is to run it through a mineral replacement filter which will alkaline the water and replace some or maybe all the minerals. Are the ingredients in the mineral replacement filter chemical free? Have they been washed by Chlorine?

The below links will show a mineral replacement filter.

Mineral Composition Filter for Hexagon Alkaline Hydrogen Water Filtration System

or

Nature2 DuoClear Mineral Replacement Cartridge Up to 35K Gallons

Do you think that this is a good idea? Should I also add oxygen to it the same way it is done in a fish tank?

Will this replace all the missing minerals and electrolytes?

Since it is stripping the minerals from anything that it touches, will it be over doing it when it passes through the mineral replacement system?

What type of container do you believe is the best to hold water without taking any of the particles? I heard that fiberglass can resist bacteria. But is it 1000% safe?

I am also planning to put some silver pieces (not colloidal silver) in the water to control the bacteria growth. I wonder if there is a negative effect on this over 50yrs or more.

Is there an easy way to test the water for the minerals after it goes through the process?

Will the minerals in the water be something like spring water after the above process is complete?

…read more

Source: DoItYourself.com

Do it yourself

need help chosing a whole house water filteration system.

Leave a comment

By Avi Shriki

I am located in Jersey City NJ I have city water, I have 4 full bath. we are 2 adults 2 children and always have a guest or two staying over. I had one technician visit me check the water and offer me a softer and r/s for $5500 plus $500 installation from rainsoft. I thought it’s a bit excessive. so before i go for an expense like this i would want to make sure I buy the best the first time around and that’s where you guys can help me. which system should I go with? here some of the results I got
Hardness: 5
Chlorine: 1.5
PH: 7.6
TDS: 140
Precipitation: 7/10

Thanks you all

…read more

Source: DoItYourself.com

Business, Finance, Occupation & Industry

Data on Provectus's PV-10 to Be Presented at the HemOnc Today – Melanoma and Cutaneous Malignancies

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Data on Provectus’s PV-10 to Be Presented at the HemOnc Today – Melanoma and Cutaneous Malignancies Conference on March 22, 2013

KNOXVILLE, Tenn.–(BUSINESS WIRE)– Provectus Pharmaceuticals, Inc. (OTCQB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, announces that data on PV-10 for metastatic melanoma will be included in a presentation at the HemOnc Today – Melanoma and Cutaneous Malignancies Conference on Friday, March 22, 2013 in New York.

Dr. Robert H.I. Andtbacka, Assistant Professor of Surgical Oncology, Huntsman Cancer Institute at the University of Utah in Salt Lake City, is scheduled to present during conference session on Local-Regional Therapy. His presentation, “Current Status of Injectable Therapy” begins at 1:55 p.m., EDT. This session will be moderated by Sanjiv S. Agarwala, MD, Principal Investigator for the Phase 2 trial of PV-10, and Chief of Medical Oncology and Hematology at St. Luke’s Hospital and Health Network in Bethlehem, PA.

Dr. Craig Dees, PhD, CEO of Provectus said, “We are pleased to be participating in this important conference. We expect Dr. Andtbacka’s presentation will support PV-10’s utility in the treatment of metastatic melanoma.”

About Provectus Pharmaceuticals, Inc.

Provectus Pharmaceuticals specializes in developing oncology and dermatology therapies. Its novel oncology drug PV-10 is designed to selectively target and destroy cancer cells without harming surrounding healthy tissue, significantly reducing potential for systemic side effects. Its oncology focus is on melanoma, breast cancer and cancers of the liver. The Company has received orphan drug designations from the FDA for its melanoma and hepatocellular carcinoma indications. Its dermatological drug PH-10 also targets abnormal or diseased cells, with the current focus on psoriasis and atopic dermatitis. Provectus has recently completed Phase 2 trials of PV-10 as a therapy for metastatic melanoma, and of PH-10 as a topical treatment for atopic dermatitis and psoriasis. Information about these and the Company’s other clinical trials can be found at the NIH registry, www.clinicaltrials.gov. For additional information about Provectus please visit the Company’s website at www.pvct.com or contact Porter, LeVay & Rose, Inc.

FORWARD-LOOKING STATEMENTS: The forward-looking statements contained herein are subject to certain risks and uncertainties that could cause actual results to differ materially from those reflected in the forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s analysis only as of the date hereof. The company undertakes no obligation to publicly revise these forward-looking statements to …read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Aetna Foundation Awards $325,000 in Grants to Train Doctors for 21st-Century Health Care

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Aetna Foundation Awards $325,000 in Grants to Train Doctors for 21 st -Century Health Care


— Funding for Institute of Medicine to help improve residency programs; launch “hotspotting” fellowships from Camden Coalition of Healthcare Providers —

HARTFORD, Conn.–(BUSINESS WIRE)– As part of its work to improve health care in the United States, the Aetna Foundation has awarded two grants totaling $325,000 to help doctors adapt to a rapidly changing health care system and growing health care needs.

The funding focuses on training young doctors for the post-reform health care landscape, which aims to improve the patient experience and population health and to lower health care costs.

“Doctors need to be part of the solution to meet the health care needs of different populations and rising rates of complex, chronic diseases,” said Gillian Barclay, D.D.S., Dr.PH., vice president of the Aetna Foundation‘s national grant making. “That means we need bold new approaches to doctors’ training to create a modern, high-performing health care system that can provide high-quality care for everyone in the U.S.”

The Aetna Foundation has contributed $150,000 to the Institute of Medicine of the National Academies (IOM) to support its study of today’s medical residency programs, or the graduate medical education system (GME).

The IOM study is looking at the governance and financing of GME in the U.S. The final report will recommend changes to medical residency programs to better prepare young doctors for 21st-century health care systems, which all increasingly focus on patient-centered primary care, team medicine and health information technology. The study also is looking at ways to encourage more doctors to specialize in primary care to meet the demands of an aging and ever more diverse U.S. population.

To conduct the study, IOM has appointed a 21-member committee with expertise in health care systems, health economics, health professions education, and financing and accreditation. The committee’s final report is expected in early 2014.

The Aetna Foundation also has awarded $175,000 to the Camden Coalition of Healthcare Providers in New Jersey to establish a new fellowship program to train primary care doctors in “hotspotting,” a technique borrowed from advancements in city policing.

In medicine, hotspotting analyzes hospital readmissions, emergency room visits and other data to identify patients who use health care resources at abnormally high rates. The …read more
Source: FULL ARTICLE at DailyFinance